drugset
drugset / Trial / NCT07308834

Evaluation of Intra-articular CX-011 to Treat Moderate to Severe Pain From Knee Osteoarthritis

NCT07308834 ↗

Phase 1/2 Not yet recruiting 72 enrolled CarthroniX, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Study is designed to evaluate the safety and effectiveness of a drug called CX-011 to treat pain in patients with osteoarthritis of the knee. Osteoarthritis produces pain in the knee (and other joints) that typically is worsened by activities such as long distance walking and is alleviated by rest.

Timeline

Start
2026-02-01
Primary completion
2028-10-30
Completion
2028-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject CX-011 Small molecule 100 ug Other
Subject CX-011 Small molecule 300 ug Other
Subject CX-011 Small molecule 1000 ug Other

Indications

osteoarthritis, knee